Literature DB >> 3250102

Long-term effects of exposure to diethylstilbestrol.

D L Wingard, J Turiel.   

Abstract

In 1985 nearly 1,700 persons who had exposure to diethylstilbestrol (DES)--520 mothers, 1,079 daughters, and 94 sons--responded to a mailed questionnaire about their general health status. Results were compared with responses to the 1985 National Health Interview Survey and other population-based studies. As with research findings in animals, conditions that suggest possibly impaired immune function--that is, respiratory tract infections, asthma, arthritis, and lupus--were reported more frequently among the persons with DES exposure. Conditions that may involve altered endocrine function were also more frequent among such persons. Given the biased sample, findings from this preliminary survey are seen as guidelines to areas meriting more rigorous research.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3250102      PMCID: PMC1026532     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  22 in total

1.  Does the administration of diethylstilbestrol during pregnancy have therapeutic value?

Authors:  W J DIECKMANN; M E DAVIS; L M RYNKIEWICZ; R E POTTINGER
Journal:  Am J Obstet Gynecol       Date:  1953-11       Impact factor: 8.661

2.  Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women.

Authors:  A L Herbst; H Ulfelder; D C Poskanzer
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

Review 3.  In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring.

Authors:  R J Stillman
Journal:  Am J Obstet Gynecol       Date:  1982-04-01       Impact factor: 8.661

4.  Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol.

Authors:  R H Kaufman; E Adam; G L Binder; E Gerthoffer
Journal:  Am J Obstet Gynecol       Date:  1980-06-01       Impact factor: 8.661

5.  Exposure to diethylstilbestrol during pregnancy permanently alters the ovary and oviduct.

Authors:  R R Newbold; B C Bullock; J A Mc Lachlan
Journal:  Biol Reprod       Date:  1983-04       Impact factor: 4.285

6.  Plasma hormones in DES-exposed females.

Authors:  C H Wu; C E Mangan; M M Burtnett; G Mikhail
Journal:  Obstet Gynecol       Date:  1980-02       Impact factor: 7.661

7.  Normal development of the human female reproductive tract and alterations resulting from experimental exposure to diethylstilbestrol.

Authors:  S J Robboy; O Taguchi; G R Cunha
Journal:  Hum Pathol       Date:  1982-03       Impact factor: 3.466

8.  Pituitary adenoma in Olmsted County, Minnesota, 1935--1977. A report of an increasing incidence of diagnosis in women of childbearing age.

Authors:  J F Annegers; C B Coulam; C F Abboud; E R Laws; L T Kurland
Journal:  Mayo Clin Proc       Date:  1978-10       Impact factor: 7.616

9.  Structure and function of the fallopian tubes following exposure to diethylstilbestrol (DES) during gestation.

Authors:  A H DeCherney; I Cholst; F Naftolin
Journal:  Fertil Steril       Date:  1981-12       Impact factor: 7.329

10.  Hirsutism and menstrual patterns in women exposed to diethylstilbestrol in utero.

Authors:  M R Peress; C C Tsai; R S Mathur; H O Williamson
Journal:  Am J Obstet Gynecol       Date:  1982-09-15       Impact factor: 8.661

View more
  7 in total

Review 1.  DNA methylation: an epigenetic risk factor in preterm birth.

Authors:  Ramkumar Menon; Karen N Conneely; Alicia K Smith
Journal:  Reprod Sci       Date:  2012-01       Impact factor: 3.060

Review 2.  Environmental exposures, epigenetic changes and the risk of lupus.

Authors:  E C Somers; B C Richardson
Journal:  Lupus       Date:  2014-05       Impact factor: 2.911

3.  Prenatal and perinatal factors and risk of multiple sclerosis.

Authors:  Hannah Gardener; Kassandra L Munger; Tanuja Chitnis; Karin B Michels; Donna Spiegelman; Alberto Ascherio
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

Review 4.  Prenatal immunotoxicant exposure and postnatal autoimmune disease.

Authors:  S D Holladay
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

Review 5.  Gender and risk of autoimmune diseases: possible role of estrogenic compounds.

Authors:  S A Ahmed; B D Hissong; D Verthelyi; K Donner; K Becker; E Karpuzoglu-Sahin
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

Review 6.  Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure.

Authors:  S D Holladay; R J Smialowicz
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

7.  The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity.

Authors:  Leah R Reznikov; David K Meyerholz; Mahmoud Abou Alaiwa; Shin-Ping Kuan; Yan-Shin J Liao; Nicholas L Bormann; Thomas B Bair; Margaret Price; David A Stoltz; Michael J Welsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-05       Impact factor: 5.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.